Trial reportPublic health reports (Washington, D.C. : 1974)
Costs of HIV prevention among out-of-treatment drug-using women: results of a randomized controlled trial.
Trial report in Public health reports (Washington, D.C. : 1974). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.
- Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future.Journal of substance abuse treatment · 2020Pooled it
- Positive Health Check evaluation: A type 1 hybrid design randomized trial to decrease HIV viral loads in patients seen in HIV primary care.Contemporary clinical trials · 2020Trial
- Estimating the costs and cost-effectiveness of HIV self-testing among men who have sex with men, United States.Journal of the International AIDS Society · 2020Trial
- The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial.Drug and alcohol dependence · 2013Trial
- Cost-effectiveness of peer-delivered interventions for cocaine and alcohol abuse among women: a randomized controlled trial.PloS one · 2012Trial
- Costs and cost-effectiveness of a collaborative data-to-care intervention for HIV treatment and care in the United States.Journal of the International AIDS Society · 2023Article
- The importance of considering polysubstance use: lessons from cocaine research.Drug and alcohol dependence · 2018Review
- A Checklist for the Conduct, Reporting, and Appraisal of Microcosting Studies in Health Care: Protocol Development.JMIR research protocols · 2016Article
- Micro-costing studies in the health and medical literature: protocol for a systematic review.Systematic reviews · 2014Article
- Costs of a motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice for pregnant substance users.PloS one · 2014Article
- Costs of addressing heroin addiction in Malaysia and 32 comparable countries worldwide.Health services research · 2012Article
- HIV rapid testing in substance abuse treatment: implementation following a clinical trial.Evaluation and program planning · 2011Article
- New strategies in the delivery of HIV-prevention services for minority groups in the U.S.Public health reports (Washington, D.C. : 1974)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
objectivesWe developed a micro-costing methodology to estimate the real resource costs consumed by delivery of the National Institute on Drug Abuse (NIDA) Cooperative Agreement Standard Intervention (SI) for human immunodeficiency virus (HIV) prevention, plus two enhanced modules, in a three-arm randomized controlled trial (RCT) among drug-using women. To our knowledge, this is the first micro-costing study of the SI and enhanced modules and the first of its kind targeting drug-using women.
methodsWe conducted a micro-costing study alongside a three-arm RCT to estimate costs of (1) the modified NIDA SI; (2) the SI and a well woman exam (SI+WWE); and (3) the SI, WWE, and four educational sessions (SI+WWE+4ES) to prevent HIV and sexually transmitted diseases in at-risk, drug-using women in St. Louis, Missouri.
resultsThe cost of the SI that all 501 participants received was approximately $227 per person. The additional costs for the WWE and 4ES were approximately $145 and $942 per person, respectively. Total program costs for the SI (n = 501) were $113,869; additional costs for the SI+WWE (n = 342) were $49,403 and for the SI+WWE+4ES (n = 170) were $160,189. The main cost component for the SI (64% of total costs) was testing costs, whereas building and facilities costs were the main cost component for the SI+WWE+4ES (75% of total costs).
conclusionsThis study provides accurate estimates of the real costs for standard and enhanced HIV interventions for policy makers seeking to implement targeted HIV-prevention programs with scarce resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.